Literature DB >> 2340809

Mutations affecting skeletal muscle myofibril structure in the zebrafish.

A L Felsenfeld1, C Walker, M Westerfield, C Kimmel, G Streisinger.   

Abstract

We describe embryonic lethal mutations in the zebrafish, Brachydanio rerio, which affect organization of skeletal muscle myofibrils. The mutations, fub-1(b45) and fub-1(b126), were independently isolated from progeny of gamma-irradiated females. Each segregates as a single recessive gene: b45 is located about 23 map units from its centromere. The b126 mutation has a similar but slightly larger apparent gene-centromere distance and a less severe phenotype. The two mutations fail to complement, suggesting that they are allelic. Homozygous b45 mutant embryos are paralyzed, and their axial skeletal muscle cells are unstriated, containing severely disorganized myofibrillar components. Gel-electrophoretic comparisons of b45 mutant and wild-type muscle proteins failed to reveal absent or altered major myofibrillar proteins. Embryos genetically mosaic for b45 were also phenotypically mosaic, suggesting that the defect is cell-autonomous. We suggest that these mutations identify a gene required for proper organization of skeletal muscle myofibrils, and that the more severe mutation may represent a null allele.

Entities:  

Mesh:

Year:  1990        PMID: 2340809     DOI: 10.1242/dev.108.3.443

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  20 in total

1.  The u-boot mutation identifies a Hedgehog-regulated myogenic switch for fiber-type diversification in the zebrafish embryo.

Authors:  S Roy; C Wolff; P W Ingham
Journal:  Genes Dev       Date:  2001-06-15       Impact factor: 11.361

2.  Connexin 39.9 protein is necessary for coordinated activation of slow-twitch muscle and normal behavior in zebrafish.

Authors:  Hiromi Hirata; Hua Wen; Yu Kawakami; Yuriko Naganawa; Kazutoyo Ogino; Kenta Yamada; Louis Saint-Amant; Sean E Low; Wilson W Cui; Weibin Zhou; Shawn M Sprague; Kazuhide Asakawa; Akira Muto; Koichi Kawakami; John Y Kuwada
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

Review 3.  Learning from small fry: the zebrafish as a genetic model organism for aquaculture fish species.

Authors:  Ralf Dahm; Robert Geisler
Journal:  Mar Biotechnol (NY)       Date:  2006-04-25       Impact factor: 3.619

4.  Glycolysis supports embryonic muscle growth by promoting myoblast fusion.

Authors:  Vanessa Tixier; Laetitia Bataillé; Christelle Etard; Teresa Jagla; Meltem Weger; Jean Philippe Daponte; Uwe Strähle; Thomas Dickmeis; Krzysztof Jagla
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 5.  The neurogenetic frontier--lessons from misbehaving zebrafish.

Authors:  Harold A Burgess; Michael Granato
Journal:  Brief Funct Genomic Proteomic       Date:  2008-10-04

6.  Identification of selected gamma-ray induced deficiencies in zebrafish using multiplex polymerase chain reaction.

Authors:  A Fritz; M Rozowski; C Walker; M Westerfield
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

7.  The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies.

Authors:  Vandana Gupta; Genri Kawahara; Stacey R Gundry; Aye T Chen; Wayne I Lencer; Yi Zhou; Leonard I Zon; Louis M Kunkel; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

Review 8.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

9.  Defective glycinergic synaptic transmission in zebrafish motility mutants.

Authors:  Hiromi Hirata; Eloisa Carta; Iori Yamanaka; Robert J Harvey; John Y Kuwada
Journal:  Front Mol Neurosci       Date:  2010-01-08       Impact factor: 5.639

10.  Muscle degeneration and leukocyte infiltration caused by mutation of zebrafish Fad24.

Authors:  Kevin B Walters; M Ernest Dodd; Jonathan R Mathias; Andrea J Gallagher; David A Bennin; Jennifer Rhodes; John P Kanki; A Thomas Look; Yevgenya Grinblat; Anna Huttenlocher
Journal:  Dev Dyn       Date:  2009-01       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.